Artwork

内容由Womble Bond Dickinson提供。所有播客内容(包括剧集、图形和播客描述)均由 Womble Bond Dickinson 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

MDMA and PTSD Treatment: Navigating Setbacks and Exploring New Directions

7:30
 
分享
 

Manage episode 439462678 series 3347948
内容由Womble Bond Dickinson提供。所有播客内容(包括剧集、图形和播客描述)均由 Womble Bond Dickinson 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In recent years, the potential of MDMA as a treatment for Post-Traumatic Stress Disorder has generated significant interest within the medical community. The drug, commonly known as ecstasy, has moved beyond its controversial recreational use to become a promising candidate for therapeutic purposes. However, the path to its approval has encountered significant hurdles. Recently, the FDA rejected Lykos Therapeutics' application for MDMA therapy, leaving many to wonder about the future of this approach.
Read the full article.

About the author:
Madeline Campbell, Ph.D.

  continue reading

205集单集

Artwork
icon分享
 
Manage episode 439462678 series 3347948
内容由Womble Bond Dickinson提供。所有播客内容(包括剧集、图形和播客描述)均由 Womble Bond Dickinson 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In recent years, the potential of MDMA as a treatment for Post-Traumatic Stress Disorder has generated significant interest within the medical community. The drug, commonly known as ecstasy, has moved beyond its controversial recreational use to become a promising candidate for therapeutic purposes. However, the path to its approval has encountered significant hurdles. Recently, the FDA rejected Lykos Therapeutics' application for MDMA therapy, leaving many to wonder about the future of this approach.
Read the full article.

About the author:
Madeline Campbell, Ph.D.

  continue reading

205集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南